Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Excerpt from Financial Times. Original publication ↗
Source: Financial Times
At a glance
- Topic
- Health
- Country
- 🇬🇧 GB
- Publisher language
- EN
- Added to Allnira